Peptide-induced modulation of synaptic transmission and escape response in Drosophila requires two G-protein-coupled receptors.
Neuropeptides are found in both mammals and invertebrates and can modulate neural function through activation of G-protein-coupled receptors (GPCRS). The precise mechanisms by which many of these GPCRs modulate specific signaling cascades to regulate neural function are not well defined. We used Drosophila melanogaster as a model to examine both the cellular and behavioral effects of DPKQDFMRFamide, the most abundant peptide encoded by the dFMRF gene. We show that DPKQDFMRFamide enhanced synaptic transmission through activation of two G-protein-coupled receptors, Fmrf Receptor (FR) and Dromyosupressin Receptor-2 (DmsR-2). The peptide increased both the presynaptic Ca(2+) response and the quantal content of released transmitter. Peptide-induced modulation of synaptic function could be abrogated by depleting intracellular Ca(2+) stores or by interfering with Ca(2+) release from the endoplasmic reticulum through disruption of either the ryanodine receptor or the inositol 1,4,5-trisphosphate receptor. The peptide also altered behavior. Exogenous DPKQDFMRFamide enhanced fictive locomotion; this required both the FR and DmsR-2. Likewise, both receptors were required for an escape response to intense light exposure. Thus, coincident detection of a peptide by two GPCRs modulates synaptic function through effects of Ca(2+)-induced Ca(2+) release, and we hypothesize that these mechanisms are involved in behavioral responses to environmental stress.
Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada. mklose@exchange.ubc.ca
Markus K
MK
Klose
Jeffrey S
JS
Dason
Harold L
HL
Atwood
Gabrielle L
GL
Boulianne
A Joffre
AJ
Mercier
D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D020013:Calcium Signaling / Q000502:physiology; D029721:Drosophila Proteins / Q000819:agonists / Q000502:physiology*; D004331:Drosophila melanogaster / Q000502:physiology*; D004924:Escape Reaction / Q000502:physiology*; D019835:FMRFamide / Q000502:physiology*; D005260:Female; D007301:Insect Hormones / Q000378:metabolism* / Q000502:physiology; D008297:Male; D009043:Motor Activity / Q000502:physiology; D009479:Neuropeptides / Q000378:metabolism* / Q000502:physiology; D018377:Neurotransmitter Agents / Q000378:metabolism / Q000502:physiology; D011498:Protein Precursors / Q000502:physiology*; D043562:Receptors, G-Protein-Coupled / Q000819:agonists / Q000502:physiology*; D018010:Receptors, Invertebrate Peptide / Q000819:agonists / Q000502:physiology; D018000:Receptors, Peptide / Q000819:agonists / Q000502:physiology*; D013312:Stress, Physiological / Q000502:physiology; D009435:Synaptic Transmission / Q000502:physiology*
D029721:Drosophila Proteins; C055209:FMRFamide receptor; D007301:Insect Hormones; C478107:MsR2 protein, Drosophila; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D011498:Protein Precursors; D043562:Receptors, G-Protein-Coupled; D018010:Receptors, Invertebrate Peptide; D018000:Receptors, Peptide; C121685:aspartyl-prolyl-lysyl-glutaminyl-aspartyl-phenylalanyl-methyonyl-arginyl-phenylalanylamide; C077905:neomyosuppressin; D019835:FMRFamide